One of the most difficult issues to be solved in genome-wide association studies is to reduce the amount of genomic DNA required for genotyping. Currently available technologies require too large a quantity of genomic DNA to genotype with hundreds or thousands of singlenucleotide polymorphisms (SNPs). To overcome this problem, we combined the Invader assay with multiplex polymerase chain reaction (PCR), carried out in the presence of antibody to Taq polymerase, as well as using a novel 384-well card system that can reduce the required reaction volume. We amplified 100 genomic DNA fragments, each containing one SNP, in a single tube, and analyzed each SNP with the Invader assay. This procedure correctly genotyped 98 of the 100 SNP loci examined in PCR-amplified samples from ten individuals; the genotypes were confirmed by direct sequencing. The reproducibility and universality of the method were confirmed with two additional sets of 100 SNPs. Because we used 40 ng of genomic DNA as a template for multiplex PCR, the amount needed to assay one SNP was only 0.4 ng; therefore, theoretically, more than 200,000 SNPs could be genotyped at once when 100 µg of genomic DNA is available. Our results indicate the feasibility of undertaking genome-wide association studies using blood samples of only 5-10 ml.
Introduction
The pathogenesis of common diseases, such as hypertension and diabetes mellitus, is thought to be caused, in some part, by common genetic variations such as single-nucleotide polymorphisms (SNPs) (Lander and Schork 1994; Lander 1996; Risch and Merikangas 1996; Collins et al. 1997; Kruglyak 1999 ). Genome-wide association studies undertaken on the basis of large-scale genotyping of SNPs in thousands of DNA samples will become one of the most potent methods for identifying genes related to complex diseases.
The Invader (Third Wave Technologies, Madison, WI, USA) assay, a method for typing SNPs, combines structurespecific cleavage enzymes with universal fluorescent probes. This assay can be applied to high-throughput genotyping (Lyamichev et al. 1999; Mein et al. 2000) , but, although it does not require polymerase chain reaction (PCR) amplification of genomic DNA (Ryan et al. 1999) , it does require 100 ng of genomic DNA to assay a single SNP. Therefore, only 1000 SNPs can be genotyped from 100µg of genomic DNA (equivalent to a 5-to 10-ml sample of whole blood). Hence, this assay is not applicable for SNP genotyping on the very large scale needed for genome-wide association studies, for which 50,000-300,000 SNPs should be typed in each individual's DNA.
To reduce the amount of DNA required to less than 1ng for the assay of a single SNP and to make genome-wide association studies feasible, we combined a multiplex PCR method with the Invader assay.
Materials and methods
Preparation of genomic DNA. Blood samples were collected from ten unrelated individuals after written informed consent was obtained from all participants. Genomic DNAs were prepared from white blood cells by standard methods.
Primer design. The sequences of the primers used in this study were the same as those developed for PCR amplification in our earlier SNP-discovery project. Information on that project, including the sequences of primers and PCR conditions, can be found on the World Wide Web at http://snp.u-tokyo.ac.jp.
Amplification of samples.
Multiplexed amplification was performed with 40 ng of genomic DNA. Each total reaction volume of 50 µl contained 50pmol of each primer, 10 units of Ex-Taq DNA polymerase (TaKaRa Shuzo, Otsu, Japan), and 0.55 µg of TaqStart (Clontech Laboratories, Palo Alto, CA, USA). Samples were amplified in the GeneAmp PCR system 9700 (Applied Biosystems, Foster City, CA). Initial denaturation was at 94°C for 2 min, followed by 35 cycles of denaturation at 94°C for 15 s, annealing at 60°C for 45s, and extension at 72°C for 3 min.
Genotyping. The Invader assay combines structure-specific cleavage enzymes and a universal fluorescent resonance energy transfer (FRET) system. Allele-specific oligonucleotide pairs and invasive probes were designed and supplied by Third Wave Technologies. FRET probes were labeled with FAM or VIC that corresponded to alleles. Signal intensity was indicated as the ratio of FAM or VIC to ROX, an internal reference. Each total reaction volume of 10 µl contained 0.5 µl of signal buffer, 0.5 µl of FRET probes, 0.5 µl of structure-specific cleavage enzyme, 1 µl of allelespecific probe mix, and 2 µl of PCR product diluted 1: 10. Samples were incubated at 95°C for 5 min, and then at 63°C for 15 min, in an ABI7700 (Applied Biosystems). In this system, when correspondent alleles exist, sigmoid or quadratic signals are detected during incubation. On the other hand, when correspondent alleles do not exist, the signal is linear.
Results
First, we randomly selected 100 genomic DNA fragments in which we had discovered at least one SNP (the data are available through our SNP database, http://snp.ims.utokyo.ac.jp) and examined whether the DNA could be amplified sufficiently in a single tube for the Invader assay ( Table 1 ). The 100 pairs of primers for DNA amplification were the same as those used for SNP screening. Simply mixing the 100 primer pairs with 40 ng of genomic DNA failed to amplify some fragments sufficiently to be validated by the Invader assay, partly owing to dimerization of primer sequences (Edwards and Gibbs 1994) . To overcome this problem, we added to the reaction solution anti-Taq polymerase antibody (TaqStart; Clontech Laboratories) (Kellogg et al. 1994) , which is known to reduce dimerization and to increase the efficiency of PCR amplification of target amplicons. Some results are shown in Fig. 1 .
To evaluate the feasibility of amplifying multiple DNA fragments prior to assay by the Invader method, we attempted to genotype genomic DNAs from the ten unrelated individuals this way. After amplification was performed, using 40 ng of genomic DNA as template, the Invader assay was performed with unique probes corresponding to each SNP allele. Figure 2a -c shows examples of real-time scanning of fluorescent signals, and indicates that 15-min incubation at 63°C can discriminate sufficiently between alleles. To simplify the genotyping procedure, in the interests of developing a high-throughput automated scoring system, we investigated the possibility of measuring fluorescentsignal intensities in two dimensions at the end of the incubation. As shown in Fig. 2d , alleles could be discriminated at a glance. By examining 100 independent SNPs, each of which was present in one of 100 amplicons, we successfully obtained correct genotypes for 98 SNPs in the ten individuals. We examined the reproducibility of the method by repeating the experiment twice, independently, for the same 100 SNPs, and obtained identical results.
To confirm the accuracy of our method, we performed direct sequencing of 24 SNP loci in all ten samples of genomic DNA (a total of 240 fragments sequenced). The SNPs were randomly selected from among the 98 that had 
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been genotyped successfully. The sequencing results were 100% identical to the genotyping data obtained by the Invader assays coupled with multiplex PCR amplification of the 100 genomic fragments. To confirm whether this method could be applied for any combination of SNPs, we evaluated it using two different sets of 100 SNPs selected from our database. The same experimental procedures again yielded high success rates; we obtained reliable signal intensities for 96 and 98 SNPs, respectively, in the two additional sets of 100 SNPs examined. We believe, therefore, that this method should be applicable to any combination of SNPs. Furthermore, to achieve a higher throughput, we developed our original 384-well reaction card (Fig. 3a) , in which only 1 µl of reaction mixture is required for one SNP assay. After samples are spotted in the well, the card is sealed tightly with an overlaid cover plate that is welded on ultrasonically. As shown in Fig. 3b , to avoid reaction mixtures contaminating each other, grooves were prepared around the reaction wells. Multiple Invader assays, using this card, provided sufficiently high fluorescent signals.
Discussion
The greatest advantage of the system described here is the significant reduction in the amount of genomic DNA required for the genotyping of a single SNP -to 0.4 ng. Even if we were to carry out a genome-wide association study involving 100,000 SNPs, only 40 µg of genomic DNA would be required from each person tested. Although 50-60 µg may be necessary for repeated experiments if genotyping fails for some SNPs, 5-to 10-ml samples of blood from any participant are likely to be sufficient. Our procedure also reduces the cost of the PCR to much less than $0.01 per SNP. The improvements described here should make genome-wide SNP genotyping more realistic and should have a great impact on studies designed to identify genes that confer susceptibility to various common diseases.
Another advantage of our system is a reduction in the time required for the Invader assay. The flow-chart in Fig. 3c illustrates the mechanics of our high-throughput genotyping system. Although a multiplex PCR process is required prior to the Invader assay, the PCR time for all SNPs is considered to total only a few minutes, because 100 fragments are amplified together. And because of the high copy-number of each target DNA fragment amplified by the PCR, 20 min of incubation and 5 min for scanning and allele discrimination are sufficient; the original protocol took 4 h. Furthermore, using our cards, we can incubate many samples simultaneously in a water bath at 63°C, and, thus, there is no need to occupy scanning machines for incubation. By our estimation, we can carry out the genotyping of 300,000-400,000 SNPs in 1 day with our high-throughput system, and this is equivalent to genotyping about 100 million SNPs over the course of a year. Fig. 2a-d At present, more than 90% of the human genomic sequence has been determined, and the next decade will be an era of "functional genome analyses", including the identification of genes related to diseases with complex traits. Genome-wide association studies should play an important role in finding genes related to diseases that do not show Mendelian inheritance. Because such studies will require the assay of hundreds of millions of SNPs, genotyping methods with very high throughput will be indispensable. Moreover, one of the most important issues in making genome-wide association studies feasible is the amount of genomic DNA required from each human participant:
Dispensing of samples
Overlaying with Plastic plate Ultrasonic welding Fig. 3a-c . High-throughput genotyping system. a Overview of the 384-well reaction card. b Method of sealing up the samples. After the wells are filled with reaction solution, each well is covered with a plastic plate. At this point, some portion of the sample overflows from the well, to keep residual air bubbles to a minimum, and the overflow is trapped by the grooves surrounding the wells. c Experimental flow-chart for Invader assay procedure, after the simultaneous PCR amplification of 100 genomic fragments, also showing the calculated amount of DNA required in each step. SNP, Single-nucleotide polymorphism the source is limited and cannot be increased by simply spending more money. Although some promising new approaches have been reported, until now, none has successfully reduced to a practicable level the amount of genomic DNA required from an individual blood sample.
Here, however, we have reported a high-throughput and highly efficient tool for genotyping SNPs. Although it merely combines easily available methods, our modification provides a way to solve the most serious practical problems in genome-wide association studies. Using the automated sample-flow system, along with our newly developed 384-well cards, we have established a protocol for genotyping up to 100 million SNPs per year.
